AzTrials
AzTrials

Heavy Episodic DrinkingNCT06976528

Understanding the Associations Between Romantic Relationship Conflict, Psychophysiological Responding and Alcohol Misuse Among Emerging Adults

A study testing Alcohol administration in people with Heavy Episodic Drinking, run by New York University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Emerging Adults (EA) engage in heavy episodic drinking (HED) at a greater quantity and frequency than any other time in their lives, which may lead to significant short- and long-term consequences. Read more about this study

Who is it for?
Ages 21 to 29 yearsHealthy volunteers can take part
Conditions the study is for
Heavy Episodic Drinking
What is being tested?
Alcohol administration
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteUnited States
Study dates
26 Sep 2025to 31 Jul 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 29 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 21-29 years old
  • Must be in a committed romantic relationship of at least 3 months duration
  • Must report at least 2 HED episodes in the past 30 days (5 or more drinks within 2 hours for males, 4 or more drinks within 2 hours for females)
  • Must self-report that they have - on at least three occasions during the past year - consumed a quantity of alcohol that is equal to or greater than the standard dose administered for their weight in the laboratory

Who cannot join

  • Meeting DSM-5 criteria for a history of or current neurological, psychotic, or bipolar disorders
  • History of self-reported head trauma requiring medical treatment
  • Body weight exceeding 250 pounds
  • Current enrollment in treatment or seeking treatment for a substance or alcohol use disorder
  • Current suicidal or homicidal intent
  • Serious cardiovascular health conditions (e.g. pacemaker, cardiac arrhythmia, hypertension) that may alter normative cardiac functioning
Show all 13Show fewer
  • Treatment on medications such as lithium, methadone, alpha or beta blockers or cholinergic/anticholinergic medications likely to confound normative cardiovascular responding or response to alcohol administration. Stimulant or benzodiazepine medication use is permissible provided participants do not take medication on the day of study participation
  • Severe and/or unilateral physical IPV with your current partner at any time
  • Sexual IPV with current partner at any time
  • Fear of current partner
  • Pregnancy or breastfeeding
  • Severe Alcohol Use Disorder (as defined by the DSM-5)
  • Current diagnosis of anorexia or bulimia

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site, 1 recruiting
  • 386 Park Avenue South

    New York, New York, 10016

    Sarah Harris, 914-419-4745, sh8527@nyu.edu

    Recruiting

Other trials in United States

About this study

Emerging Adults (EA) engage in heavy episodic drinking (HED) at a greater quantity and frequency than any other time in their lives, which may lead to significant short- and long-term consequences. Although much is known about the influence of peers in EA alcohol use, there is a dearth of research examining the ways in which romantic partners influence EA drinking behaviors. The proposed study bridges a crucial gap in the existing literature by examining behavioral and physiological risk and resilience factors in the acute link between EA relationship conflict and alcohol consumption. EA couples will engage in two conflict resolution tasks interspersed with two puzzle tasks and two alcohol administration procedures. Because high frequency heart rate variability (HF-HRV) is associated with alcohol use and emotion regulation during stressful experiences, HF-HRV and other physiological data will be collected throughout the laboratory procedures.

Being tested
Alcohol administration
Keywords
couples, emerging adults, young adults, binge drinking, alcohol use, conflict
Medical subject headings
Binge Drinking, Alcohol Drinking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Alcohol administrationOther

    In this study, participants complete two tasks, then are administered alcohol. Next, they repeat the tasks.

Study groups in NCT06976528
Study groupRoleWhat they receive
Single ArmExperimentalThis is the only arm of the study. All participants receive the alcohol administration intervention.
Receives: Other: Alcohol administration

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Alcohol consumption

    Amount of alcohol consumed during the study

    Measured: ~20 minutes

Secondary outcomes (1)
  1. High frequency heart rate variability (HF-HRV)

    High frequency heart rate variability (HF-HRV) is a neurally-derived measure of parasympathetic activity that may partially explain the association between stressful relationship conflict and alcohol misuse. HF-HRV is a measure of the variability in interbeat intervals, or the time in between beats of the heart.

    Measured: ~3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 May 2025
  2. Study start26 Sep 2025
  3. Primary completion31 Jul 2028 (estimated)
  4. Study completion31 Jul 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06976528
Sponsor's protocol ID
20237802
Other IDs
5K23AA030328
Status last verified
Sep 2025
First submitted
8 May 2025
Last updated
10 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Alcohol administration in people with Heavy Episodic Drinking, run by New York University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Alcohol consumption (time frame: ~20 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in